tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
Holding ABUS?
Track your performance easily

Arbutus Biopharma (ABUS) Income Statement

1,217 Followers

Arbutus Biopharma Income Statement

Last quarter (Q3 2024), Arbutus Biopharma's total revenue was $1.34M, a decrease of -71.25% from the same quarter last year. In Q3, Arbutus Biopharma's net income was $-19.72M. See Arbutus Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 6.74M$ 18.14M$ 39.02M$ 10.99M$ 6.91M$ 6.01M
Cost of Revenue
----$ 47.48M-
Gross Profit
$ 6.74M$ 18.14M$ 39.02M$ 10.99M$ -40.57M$ 6.01M
Operating Expense
$ 89.81M$ 96.17M$ 102.24M$ 84.51M$ 64.72M$ -149.91M
Operating Income
$ -83.13M$ -78.10M$ -65.46M$ -73.52M$ -57.81M$ -71.34M
Net Non Operating Interest Income Expense
$ 6.46M$ 5.23M$ 466.00K$ -2.73M$ -3.27M$ 3.00K
Other Income Expense
$ 1.23M$ -44.00K$ -2.25M$ 2.04M$ 3.00M$ 66.19M
Pretax Income
$ -75.61M$ -72.85M$ -65.01M$ -76.41M$ -63.73M$ -166.38M
Tax Provision
--$ 4.44M--$ -12.66M
Earnings From Equity Interest Net Of Tax
----$ -2.54M$ -22.52M
Net Income Common Stockholders
$ -76.43M$ -72.85M$ -69.46M$ -88.39M$ -75.87M$ -164.87M
Basic EPS
$ -0.43$ -0.44$ -0.46$ -0.83$ -1.00$ -0.46
Diluted EPS
$ -0.43$ -0.44$ -0.46$ -0.83$ -1.00$ -2.89
Basic Average Shares
$ 721.29M$ 165.96M$ 150.94M$ 106.24M$ 75.84M$ 57.09M
Diluted Average Shares
$ 721.29M$ 165.96M$ 150.94M$ 106.24M-$ 37.04M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 89.88M$ 96.17M$ 102.24M$ 84.51M$ 64.72M$ -149.91M
Net Income From Continuing And Discontinued Operation
$ -76.70M$ -72.85M$ -69.46M$ -76.25M$ -63.74M$ -153.72M
Normalized Income
$ -34.64M-----
Interest Expense
------
EBIT
$ -76.58M$ -72.39M$ -63.29M$ -73.39M$ -59.72M$ -164.27M
EBITDA
$ -74.62M$ -70.99M$ -61.86M$ -71.64M$ -57.76M$ -162.52M
Currency in USD

Arbutus Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis